Fagron Recalls SyrSpend SF Suspending Base Due to Yeast Contamination
Fagron, Inc. is recalling SyrSpend SF Suspending Base because the product contains yeast. The recall covers 88 bottles distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The hazard is microbial contamination (yeast) in a non-sterile product, which fits the criteria for moderate severity involving low-risk contamination or voluntary precautionary measures without reported serious injuries.
Plain-English summary
Fagron, Inc. is recalling SyrSpend SF, Suspending Base, a sweetened, sugar-free syrup-suspending vehicle used for preparing oral liquid dose forms. The recall is being conducted due to the presence of yeast in the product.
The affected product is the 4 L bottle, identified by NDC 51552-1079-9. The recall includes 88 bottles from Lot #s 15J26-U05-027457 and 15J26-U05-027473. These products were distributed nationwide.
Consumers and healthcare providers should check their inventory for these specific lot numbers and stop using the product if it matches the recalled description.
The recalled product
- Product
- SyrSpend SF, Suspending Base, a convenient, sweetened, sugar-free syrup-suspending vehicle specially formulated to assist in extemporaneous preparation of oral liquid dose forms, Rx Only, Shake Well, 4 L bottle, Manufactured by Fagron Inc., St. Paul, MN 55120, NDC 51552-1079-9.
- Manufacturer
- Fagron, Inc
- Category
- Drug — Pharmaceutical Excipient
- Affected units
- 88
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #s: 15J26-U05-027457
- 15J26-U05-027473
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Fagron, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Fagron, Inc
See all →- HighNystatin Bulk Powder Recalled Due to Incorrect Label Strength
FDA (Drugs) · 2023-12-27
- HighNystatin Bulk Powder Recall for Incorrect Label Assay Value
FDA (Drugs) · 2023-12-27
- HighNystatin Powder Recall Due to Incorrect Assay Strength on Label
FDA (Drugs) · 2023-12-27
- HighNystatin bulk powder recall due to incorrect assay strength label
FDA (Drugs) · 2023-12-27
- ModeratePrescription Compounding Drug Nandrolone Decanoate Recalled for Subpotency
FDA (Drugs) · 2022-05-18
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereFagron Recalls SyrSpend SF Suspending Base Due to Microbial Contamination
FDA (Drugs) · 2018-03-07
- SevereSyrSpend SF Suspending Base Recalled for Burkholderia Contamination
FDA (Drugs) · 2022-05-18
- SevereFagron Recalls Pentravan Base Due to Mold Contamination
FDA (Drugs) · 2014-08-06
- ModerateFagron Recalls Estrone Compounding Powder Due to Quality Assurance Deviations
FDA (Drugs) · 2017-05-31
- ModerateFagron Recalls Estriol Compounding Powder Due to Quality Assurance Deviations
FDA (Drugs) · 2017-05-31
- SevereFagron Recalls Neostigmine Methylsulfate Syringes Due to Labeling Error
FDA (Drugs) · 2018-07-11